FIELD: biotechnology, medicine.
SUBSTANCE: Pcup1-Aβ-SUS35MC hybrid gene is produced on the base of CUP1 promoter, sequence encoding of full-length human amyloid beta (Aβ) peptide, sequence encoding of M and C domains of Sup35 protein of Saccharomyces cerevisiae, and translation terminating sequence.
EFFECT: method for scale screening of Aβ-peptide aggregation regulating agents.
2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE COMPOUND, USEFUL FOR INHIBITING FORMATION OF AMYLOID PLAQUES | 2011 |
|
RU2588143C2 |
| ANIMAL MODEL OF ZINC-DEPENDENT AMYLOIDOGENESIS IN ALZHEIMER'S DISEASE | 2021 |
|
RU2781331C1 |
| EPITOPE, SPECIFIC TO AMYLOID BETA OLIGOMER AND ANTIBODIES | 2011 |
|
RU2644335C2 |
| ELECTROCHEMICAL METHOD OF DETECTING AMINO ACID SUBSTITUTIONS AND IDENTIFYING PEPTIDES | 2016 |
|
RU2633078C2 |
| HYDROCORTISONE DERIVATIVE FOR ALZHEIMER'S DISEASE TREATMENT | 2019 |
|
RU2748437C2 |
| 4-(3-((2-ADAMANTYL)AMINO)-3-OXOPROP-1-EN-1-YL)-N-HYDROXYBENZAMIDE - A NEW DRUG FOR THE TREATMENT OF ALZHEIMER'S DISEASE | 2022 |
|
RU2783995C1 |
| VACCINE AGAINST INTERMEDIATE WITH AMYLOID COAGULATION | 2009 |
|
RU2546234C2 |
| SAFE AND FUNCTIONAL HUMANIZED ANTIBODIES | 2011 |
|
RU2607368C2 |
| PEPTIDE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | 2018 |
|
RU2679080C1 |
| ELECTROCHEMICAL METHOD FOR EXPRESS-ANALYSIS OF AMYLOID-BETA WITH METAL IONS | 2015 |
|
RU2585307C1 |
